COMPARISON OF TREATMENT EFFICACY IN PAROXYSMAL ATRIAL FIBRILLATION

COMPARISON OF TREATMENT EFFICACY IN PAROXYSMAL ATRIAL FIBRILLATION

Aim. To compare efficacy of nebivolol (Nb) and sotalol (St) in patients with paroxysmal atrial fibrillation (AF) at the background of arterial hypertension (AH) and\or coronary heart disease (CHD), taken the influence on “regulatory-adaptive status” (RS).Material and methods. Totally, 60 patients in...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. G. Tregubov, M. A. Eremina, S. G. Kanorsky, V. M. Pokrovsky
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2017-04-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	regulatory-adaptive status paroxysmal atrial fibrillation nebivolol sotalol
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/422
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

REGULATORY-ADAPTIVE STATUS IN COMPARISON OF BISOPROLOL AND SOTALOL EFFICACY IN VENTRICULAR RHYTHM DISORDERS
by: V. G. Tregubov, et al.
Published: (2018-03-01)

Hearing the Vagus Nerve’s Rhythm in Patients with Paroxysmal Atrial Fibrillation
by: A. A. Nechepurenko, et al.
Published: (2020-07-01)

Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01)

Propafenone efficacy in paroxysmal atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2004-12-01)

COMPARE THE EFFECTIVENESS OF NEBIVOLOL AND SOTALOL IN PATIENTS WITH HYPERTENSIVE DISEASE AND VENTRICULAR ARRHYTHMIAS
by: I. Z. Shubitidze, et al.
Published: (2016-09-01)

STRUCTURAL AND ELECTROPHYSIOLOGICAL PREDICTORS OF A PAROXYSM OF ATRIAL FIBRILLATION
by: B. G. Iskenderov, et al.
Published: (2001-08-01)

Propafenone and amiodarone efficacy in paroxysmal atrial fibrillation treatment
by: N. N. Isakova, et al.
Published: (2006-06-01)

Heart rate variability and trans-esophageal atrial stimulation data in predicting recurrent atrial fibrillation paroxysms
by: T. V. Setyn, et al.
Published: (2007-12-01)

Radiofrequency or cryoablation or medical therapy for paroxysmal atrial fibrillation: An indirect comparison of effectiveness
by: Roberto Brunoro, et al.
Published: (2025-04-01)

Distribution Patterns of Paroxysmal Atrial Fibrillation Triggers and Catheter Ablation Success Rates
by: Dongsheng Zhao, et al.
Published: (2025-03-01)

Maintenance and Reversibility of Paroxysmal Atrial Fibrillation in JDP2 Overexpressing Mice
by: Gerhild Euler, et al.
Published: (2025-07-01)

Machine-learning model for predicting left atrial thrombus in patients with paroxysmal atrial fibrillation
by: Wanli Xiong, et al.
Published: (2025-06-01)

Mechanisms of paroxysmal atrial fibrillation in patients with sick sinus syndrome
by: S. Yu. Ivanov, et al.
Published: (2004-08-01)

CARDIOVERSION WITH BI- AND MONOPHASE DEFIBRILLATORS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION
by: V. A. Lusov, et al.
Published: (2010-02-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

ANTIARRHYTMIC EFFICACY OF SOTALOL IN PATIENTS WITH TACHY-BRADY SYNDROME HAVING ATRIAL PACEMAKER WITH DIFFERENT ATRIAL ELECTRODE POSITION
by: T. N. Novikova
Published: (2016-01-01)

Fluid retention in patients with paroxysmal and permanent atrial fibrillation and heart failure
by: V. V. Kirillova, et al.
Published: (2020-11-01)

Prolonged ECG monitoring: indications for paroxysmal atrial fibrillation diagnostics in coronary heart disease patients
by: S. Yu. Ivanov, et al.
Published: (2006-06-01)

Pulsed‐Field Ablation Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation: A Systematic Review and Meta‐Analysis
by: Inês Martins Esteves, et al.
Published: (2025-08-01)

ADVERSE PROGNOSTIC FACTORS FOR THE CATHETER ISOLATION OF PULMONARY VEINS OSTIA EFFICACY IN PAROXYSMAL ATRIAL FIBRILLATION WITH NO ORGANIC HEART PATHOLOGY (THE PRUF STUDY)
by: A. V. Tarasov, et al.
Published: (2017-04-01)

The impact of left atrial voltage abnormality on ablation outcomes in paroxysmal atrial fibrillation and its pre-procedural predictors: an observational retrospective study
by: Dongsheng Zhao, et al.
Published: (2025-07-01)

ASSESSMENT OF THE EFFICACY OF CATHETER ISOLATION OF PULMONARY VEINS OSTIA FOR TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION WITH ANTIARRHYTHMIC THERAPY IN EARLY POST-SURGERY PERIOD (THE PRUF STUDY)
by: A. V. Tarasov, et al.
Published: (2017-02-01)

Association between plasma trimethylamine N-oxide level and atrial fibrillation
by: YANG Wentao, ZHAO Qing, LI Xiangdong, WANG Yutang, LIU Wei
Published: (2025-04-01)

REGULATORY-ADAPTIVE STATE IN EVALUATION OF BISOPROLOL AND NEBIVOLOL THERAPY EFFECTIVENESS FOR VENTRICULAR ARRHYTHMIA
by: I. Z. Shubitidze, et al.
Published: (2016-12-01)

Optimized workflow for paroxysmal atrial fibrillation ablation using very high power short duration
by: Lorenzo Gigli, et al.
Published: (2025-02-01)

Rare genetic variants involved in increased risk of paroxysmal atrial fibrillation in a Japanese population
by: Kanji Tabata, et al.
Published: (2025-04-01)

Prognostic Value of Spontaneous Potential in Left Atrial Posterior Wall Isolation and Radiofrequency Ablation for Non-Paroxysmal Atrial Fibrillation
by: Chen ZY, et al.
Published: (2025-07-01)

THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Study of the Effect of Proton Pump Inhibitors on the Development of Hypomagnesemia in Patients with Paroxysmal Atrial Fibrillation on the Background of Autonomic Sinus Node Dysfunction
by: Ya. G. Bozhko, et al.
Published: (2020-01-01)

Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter
by: D. A. Gagloeva, et al.
Published: (2023-05-01)

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspective
by: Malte Kuniss, et al.
Published: (2024-11-01)

Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation
by: Xinzhong Li, et al.
Published: (2025-03-01)

Heart rate variability and trans-esophageal atrial stimulation data in predicting recurrent atrial fibrillation paroxysms
by: T. V. Setyn, et al.
Published: (2007-04-01)

Association of iron deficiency with atrial fibrillation recurrence after pharmacological cardioversion
by: M. Kh. Valeev, et al.
Published: (2023-07-01)

Comparison of traditional radiofrequency ablation and high-power short-duration ablation in the treatment of atrial tachyarrhythmias
by: A. V. Yakushev, et al.
Published: (2022-09-01)

THE PROPANORM EFFICACY IN RAPID RELIEF OF SYMPTOMS OF PAROXYSMAL AURICULAR FIBRILLATION
by: N. N. Borovkov, et al.
Published: (2003-10-01)

Predictors and prognosis of elderly hip fracture patients with perioperative atrial fibrillation: a nested case–control study
by: Wei Li, et al.
Published: (2025-01-01)

Echocardiographic assessment of left atrial structural and functional changes after catheter ablation in paroxysmal atrial fibrillation with preserved ejection fraction
by: Qi Zhang, et al.
Published: (2025-08-01)

Does it make sense to study heart rate variability in episodes of paroxysmal atrial fibrillation during the 24-hour electrocardiographic monitoring?
by: M. V. Arkhipov, et al.
Published: (2022-08-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
by: K. A. Skiba, et al.
Published: (2003-06-01)